馥感啉口服液治疗小儿急性上呼吸道感染53例
馥感啉口服液治疗小儿急性上呼吸道感染53例
吴启富
【摘要】目的观察馥感啉口服液治疗儿童急性上呼吸道感染的疗效及应用价值。方法:选择110例急性上呼吸道感染患儿,随机分成治疗组和对照组。治疗组给予馥感啉口服液,对照组应用双黄连口服液,疗程3天。观察两组治疗前后临床症状体征改善情况。结果治疗组脱落2例,对照组脱落4例;疾病疗效,治疗组临床控制率67.92%、总有效率90.57%,对照组分别为39.22%、70.59%(P<0.05);中医证候疗效,治疗组临床控制率75.47%、总有效率94.34%,对照组分别为45.10%、74.51%(P<0.05);两组临床症状体征改善情况比较差异有统计学意义(P<0.05);治疗组比对照组退热速度更快,作用更强,维持退热时间更长(P<0.05);不良反应少而轻。结论:馥感啉口服液治疗儿童急性上呼吸道感染疗效显著,快速安全,具有较高的临床应用价值。
【关键词】馥感啉口服液;双黄连口服液;急性上呼吸道感染;儿童
Effects of fuganlin liquid treatment of 53 cases with acute upper respiratory infection. Wu Qifu, The Material and Children Health Hospital, Huaying 638600, Sichuan, China
【Abstract】 Objective To study the clinical effect and application value of Fuganlin Liquid on children with acute upper respiratory infection (AURI). Methods One hundred ten AURI children were randomly divided into treatment group (55 cases) and control group (55 cases). Patients in the treatment group were treated with Fuganlin Liquid and in the control group with Shuanghuanglian Oral Liquid. All the treatments lasted for 3 days. And then the symptoms and signs were observed and compared. Results Two patients fell off in the treatment group and 4 fell off in the control group. There were statistical differences in total effective rate and curative rate between two groups (90.57% vs 70.59%, 67.92% vs 39.22%, P<0.05). There were statistical differences in total effective rate and curative rate of syndrome of traditional Chinese medicine (94.34% vs 74.519%, 75.47% vs 45.10%, P<0.05). The improvement of symptoms and signs were superior in the treatment group to that of the control group (P<0.05). Fuganlin Liquid had faster antipyretic velocity and stronger antipyretic capability, and demonstrated longer temperature normalization(P<0.05). Conclusion Fuganlin Liquid on children with acute upper respiratory infection shows fast and good effect with little side one, and it is worthy of application.
【Key words】Fuganlin liquid; shuanghuanglian oral liquid; acute upper respiratory infection; children